nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2D6—Parkinson's disease	0.527	0.583	CbGaD
Loratadine—ABCB1—Parkinson's disease	0.377	0.417	CbGaD
Loratadine—Desloratadine—CYP2D6—Parkinson's disease	0.00194	0.583	CrCbGaD
Loratadine—Desloratadine—ABCB1—Parkinson's disease	0.00139	0.417	CrCbGaD
Loratadine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	6.28e-05	0.000678	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TALDO1—Parkinson's disease	6.27e-05	0.000677	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—OMD—Parkinson's disease	6.27e-05	0.000677	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	6.2e-05	0.00067	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.96e-05	0.000644	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ND3—Parkinson's disease	5.95e-05	0.000643	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MCCC1—Parkinson's disease	5.95e-05	0.000643	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	5.94e-05	0.000642	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.86e-05	0.000634	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.81e-05	0.000628	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ND3—Parkinson's disease	5.81e-05	0.000627	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.81e-05	0.000627	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.76e-05	0.000622	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GCH1—Parkinson's disease	5.67e-05	0.000612	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TALDO1—Parkinson's disease	5.59e-05	0.000604	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—OMD—Parkinson's disease	5.59e-05	0.000604	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.52e-05	0.000596	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.49e-05	0.000593	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	5.49e-05	0.000593	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.48e-05	0.000592	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ND3—Parkinson's disease	5.47e-05	0.000591	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.47e-05	0.000591	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—OMD—Parkinson's disease	5.46e-05	0.00059	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TALDO1—Parkinson's disease	5.46e-05	0.00059	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.44e-05	0.000588	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	5.42e-05	0.000586	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ND3—Parkinson's disease	5.42e-05	0.000586	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	5.42e-05	0.000586	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.41e-05	0.000585	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	5.41e-05	0.000585	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	5.4e-05	0.000583	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	5.3e-05	0.000573	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	5.2e-05	0.000562	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	5.18e-05	0.000559	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	5.17e-05	0.000559	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.14e-05	0.000556	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—OMD—Parkinson's disease	5.14e-05	0.000556	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.11e-05	0.000552	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—OMD—Parkinson's disease	5.1e-05	0.000551	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	5.1e-05	0.000551	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	5.09e-05	0.00055	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GCH1—Parkinson's disease	5.06e-05	0.000547	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—FBP1—Parkinson's disease	5.05e-05	0.000546	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—DBH—Parkinson's disease	5.05e-05	0.000546	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GBA—Parkinson's disease	5.05e-05	0.000546	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.05e-05	0.000545	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	5e-05	0.00054	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.98e-05	0.000538	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GCH1—Parkinson's disease	4.94e-05	0.000533	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.88e-05	0.000527	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	4.84e-05	0.000523	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	4.83e-05	0.000522	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	4.7e-05	0.000508	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	4.67e-05	0.000504	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.65e-05	0.000503	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	4.63e-05	0.0005	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GCH1—Parkinson's disease	4.61e-05	0.000498	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.56e-05	0.000493	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	4.54e-05	0.00049	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.52e-05	0.000488	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—FBP1—Parkinson's disease	4.51e-05	0.000487	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GBA—Parkinson's disease	4.51e-05	0.000487	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—DBH—Parkinson's disease	4.51e-05	0.000487	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PENK—Parkinson's disease	4.42e-05	0.000478	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAG—Parkinson's disease	4.42e-05	0.000478	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—DBH—Parkinson's disease	4.4e-05	0.000475	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GBA—Parkinson's disease	4.4e-05	0.000475	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—FBP1—Parkinson's disease	4.4e-05	0.000475	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	4.39e-05	0.000475	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	4.38e-05	0.000473	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	4.38e-05	0.000473	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.16e-05	0.00045	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—DBH—Parkinson's disease	4.15e-05	0.000448	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.15e-05	0.000448	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GBA—Parkinson's disease	4.15e-05	0.000448	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—DBH—Parkinson's disease	4.11e-05	0.000444	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GBA—Parkinson's disease	4.11e-05	0.000444	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—FBP1—Parkinson's disease	4.11e-05	0.000444	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.1e-05	0.000443	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	4.05e-05	0.000437	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	3.97e-05	0.000429	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	3.97e-05	0.000429	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.94e-05	0.000426	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.84e-05	0.000415	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	3.8e-05	0.000411	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	3.76e-05	0.000406	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—DDC—Parkinson's disease	3.71e-05	0.000401	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.69e-05	0.000399	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.62e-05	0.000391	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ND3—Parkinson's disease	3.58e-05	0.000387	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.58e-05	0.000387	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	3.5e-05	0.000379	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTA4—Parkinson's disease	3.5e-05	0.000378	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.46e-05	0.000374	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.36e-05	0.000363	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—OMD—Parkinson's disease	3.36e-05	0.000363	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.34e-05	0.000361	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—DDC—Parkinson's disease	3.31e-05	0.000358	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	3.3e-05	0.000356	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—DDC—Parkinson's disease	3.23e-05	0.000349	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.21e-05	0.000347	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	3.2e-05	0.000346	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.19e-05	0.000345	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	3.18e-05	0.000344	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	3.15e-05	0.000341	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	3.12e-05	0.000338	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MAOB—Parkinson's disease	3.12e-05	0.000337	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.09e-05	0.000333	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.06e-05	0.000331	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.05e-05	0.00033	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—DDC—Parkinson's disease	3.04e-05	0.000329	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.04e-05	0.000329	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—DDC—Parkinson's disease	3.02e-05	0.000326	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.97e-05	0.000321	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INSR—Parkinson's disease	2.95e-05	0.000319	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.87e-05	0.000311	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.87e-05	0.00031	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.85e-05	0.000308	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	2.81e-05	0.000304	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.81e-05	0.000304	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGB—Parkinson's disease	2.79e-05	0.000301	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MAOB—Parkinson's disease	2.79e-05	0.000301	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	2.78e-05	0.000301	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	2.77e-05	0.0003	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.75e-05	0.000297	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	2.73e-05	0.000295	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MAOB—Parkinson's disease	2.72e-05	0.000294	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.71e-05	0.000293	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.71e-05	0.000293	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.71e-05	0.000293	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	2.68e-05	0.00029	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.65e-05	0.000286	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	2.6e-05	0.00028	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.59e-05	0.00028	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.57e-05	0.000277	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.56e-05	0.000277	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.54e-05	0.000274	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	2.42e-05	0.000262	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.42e-05	0.000261	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	2.35e-05	0.000254	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	2.35e-05	0.000254	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	2.32e-05	0.000251	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CTGF—Parkinson's disease	2.28e-05	0.000246	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	2.12e-05	0.000229	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NQO1—Parkinson's disease	2.1e-05	0.000227	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	2.07e-05	0.000224	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TH—Parkinson's disease	2.07e-05	0.000223	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CTGF—Parkinson's disease	2.03e-05	0.00022	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.02e-05	0.000218	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.99e-05	0.000215	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYCS—Parkinson's disease	1.98e-05	0.000214	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CTGF—Parkinson's disease	1.98e-05	0.000214	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	1.97e-05	0.000213	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	1.9e-05	0.000205	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.89e-05	0.000205	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.89e-05	0.000204	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.88e-05	0.000203	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	1.88e-05	0.000203	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.87e-05	0.000202	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.87e-05	0.000202	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.85e-05	0.0002	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.85e-05	0.0002	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TH—Parkinson's disease	1.85e-05	0.000199	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.83e-05	0.000197	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TH—Parkinson's disease	1.8e-05	0.000195	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.77e-05	0.000191	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—COMT—Parkinson's disease	1.76e-05	0.00019	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTP1—Parkinson's disease	1.75e-05	0.000189	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MAOA—Parkinson's disease	1.75e-05	0.000189	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.74e-05	0.000188	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYCS—Parkinson's disease	1.73e-05	0.000187	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NGF—Parkinson's disease	1.73e-05	0.000187	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.73e-05	0.000187	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMOX1—Parkinson's disease	1.73e-05	0.000186	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.72e-05	0.000186	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.71e-05	0.000184	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TH—Parkinson's disease	1.7e-05	0.000183	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.69e-05	0.000183	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TH—Parkinson's disease	1.68e-05	0.000182	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.67e-05	0.000181	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.66e-05	0.000179	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	1.64e-05	0.000178	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.63e-05	0.000176	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.62e-05	0.000175	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1.61e-05	0.000174	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—COMT—Parkinson's disease	1.57e-05	0.00017	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.56e-05	0.000169	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.56e-05	0.000168	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.54e-05	0.000166	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GPX1—Parkinson's disease	1.54e-05	0.000166	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—COMT—Parkinson's disease	1.53e-05	0.000165	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APOE—Parkinson's disease	1.53e-05	0.000165	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.52e-05	0.000165	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MAOA—Parkinson's disease	1.52e-05	0.000164	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.5e-05	0.000162	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.48e-05	0.00016	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.44e-05	0.000156	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.44e-05	0.000155	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.43e-05	0.000155	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.43e-05	0.000155	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—COMT—Parkinson's disease	1.43e-05	0.000155	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.42e-05	0.000154	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—Parkinson's disease	1.42e-05	0.000154	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.42e-05	0.000153	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.42e-05	0.000153	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.4e-05	0.000152	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.4e-05	0.000151	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.37e-05	0.000148	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.36e-05	0.000147	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.35e-05	0.000146	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GPX1—Parkinson's disease	1.34e-05	0.000145	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—APOE—Parkinson's disease	1.32e-05	0.000143	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.32e-05	0.000143	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.31e-05	0.000141	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INS—Parkinson's disease	1.31e-05	0.000141	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.27e-05	0.000137	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.26e-05	0.000137	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.25e-05	0.000135	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.24e-05	0.000135	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.24e-05	0.000134	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.22e-05	0.000132	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—APOE—Parkinson's disease	1.18e-05	0.000128	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.17e-05	0.000126	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.16e-05	0.000125	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—APOE—Parkinson's disease	1.15e-05	0.000125	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.14e-05	0.000123	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—INS—Parkinson's disease	1.13e-05	0.000122	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.13e-05	0.000122	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TH—Parkinson's disease	1.11e-05	0.00012	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.09e-05	0.000117	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—APOE—Parkinson's disease	1.08e-05	0.000116	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.07e-05	0.000115	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—INS—Parkinson's disease	1.01e-05	0.000109	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—INS—Parkinson's disease	9.84e-06	0.000106	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	9.72e-06	0.000105	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	9.66e-06	0.000104	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—COMT—Parkinson's disease	9.43e-06	0.000102	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	9.39e-06	0.000101	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MAOA—Parkinson's disease	9.37e-06	0.000101	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—INS—Parkinson's disease	9.28e-06	0.0001	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	9.26e-06	0.0001	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—INS—Parkinson's disease	9.2e-06	9.94e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	8.93e-06	9.65e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.89e-06	9.6e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.63e-06	9.32e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.26e-06	8.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.63e-06	8.24e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—APOE—Parkinson's disease	7.1e-06	7.67e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—INS—Parkinson's disease	6.06e-06	6.55e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—Parkinson's disease	5.7e-06	6.16e-05	CbGpPWpGaD
